Liver Tumors
Objective 
1. Identify the most important features of 
common benign liver tumors 
2. Know the risk factors, diagnosis, and 
management of hepatocellular 
carcinoma 
 
Classification 
Hemangioma 
Focal nodular 
hyperplasia 
Adenoma 
Liver cysts 
1. Primary liver 
cancers 
Hepatocellular 
carcinoma 
Fibrolamellar carcinoma 
Hepatoblastoma 
 
2.  Metastases 
Benign  Malignant 
Benign Liver Lesions 
1. Hemangioma 
2. Focal nodular hyperplasia 
3. Adenoma 
4. Cysts 
Hemangioma 
Clinical Features 
The commonest liver tumor 
5% of autopsies 
Usually single small 
Well demarcated capsule 
Usually asymptomatic 
 
Hemangioma 
Diagnosis and Management 
Diagnosis 
US: echogenic spot, well demarcated 
CT: venous enhancement from periphery to 
center 
MRI: high intensity area 
No need for FNA 
 
Treatment 
No need for treatment 
CT/Hemangioma 
Focal Nodular Hyperplasia (FNH) 
Clinical Features 
Benign nodule formation of normal liver 
tissue 
Central stellate scar 
More common in young and middle age 
women 
No relation with sex hormones 
Usually asymptomatic 
May cause minimal pain 
Focal Nodular Hyperplasia (FNH) 
Diagnosis and Management 
Diagnosis: 
US: Nodule with varying echogenicity 
CT: Hypervascular mass with central scar 
MRI: iso or hypo intense  
FNA: Normal hepatocytes and Kupffer cells with 
central core. 
 
Treatment: 
No treatment necessary 
Pregnancy and hormones OK 
CT/FNH 
Hepatic Adenoma 
Clinical features 
Benign neoplasm composed of normal 
hepatocytes no portal tract, central veins, 
or bile ducts 
More common in women 
Associated with contraceptive hormones 
Usually asymptomatic but may have RUQ 
pain 
Mat presents with rupture, hemorrhage, or 
malignant transformation (very rare)   
Hepatic Adenoma 
Diagnosis and Management 
DX 
US: filling defect 
CT: Diffuse arterial enhancement 
MRI: hypo or hyper intense lesion 
FNA : may be needed 
 
Tx 
Stop hormones 
Observe every 6m for 2 y 
If no regression then surgical excision 
 
Adenoma 
Liver Cysts 
May be single or multiple 
May be part of polycystic kidney disease 
Patients often asymptomatic 
No specific management required 
Hydated cyst 
Malignant Liver Lesions 
Malignant Liver Tumors 
1. Hepatocellular carcinoma (HCC) 
2. Fibro-lamellar carcinoma of the liver 
3. Hepatoblastoma 
4. Intrahepatic cholangiocarcinoma 
5. Others 
HCC: Incidence 
The most common primary liver cancer 
The most common tumor in Saudi men 
Increasing in US and all the world 
HCC: Risk Factors 
The most important risk factor is cirrhosis 
from any cause: 
1. Hepatitis B (integrates in DNA) 
2. Hepatitis C 
3. Alcohol 
4. Aflatoxin 
5. Other 
HCC: Clinical Features 
Wt loss and RUQ pain (most common) 
Asymptomatic 
Worsening of pre-existing chronic liver dis 
Acute liver failure 
O/E: 
Signs of cirrhosis 
Hard enlarged RUQ mass 
Liver bruit (rare) 
 
HCC: Metastases 
Rest of the liver 
Portal vein 
Lymph nodes 
Lung 
Bone 
Brain 
HCC: Systemic Features 
Hypercalcemia 
Hypoglycemia 
Hyperlipidemia 
Hyperthyroidism 
 
HCC: labs 
Labs of liver cirrhosis 
 
AFP (Alfa feto protein) 
Is an HCC tumor marker 
Values more than 100ng/ml are highly 
suggestive of HCC 
Elevation seen in more than 70% of pt 
HCC: Diagnosis 
Clinical presentation 
Elevated AFP 
US 
Triphasic CT scan: very early arterial 
perfusion 
MRI 
Biopsy 
US: HCC 
CT: Venous Phase 
CT: Arterial Phase 
HCC: Prognosis 
Tumor size 
Extrahepatic spread 
Underlying liver disease 
Pt performance status 
HCC: Liver 
Transplantation 
Best available treatment 
Removes tumor and liver 
Only if single tumor less than 5cm or less 
than 3 tumors less than 3 cm each 
Recurrence rate is low 
Not widely available 
 
HCC: Resection 
Feasible for small tumors with preserved 
liver function (no jaundice or portal HTN) 
Recurrence rate is high 
 
HCC: Local Ablation 
For non resectable pt 
For pt with advanced liver cirrhosis 
Alcohol injection 
Radiofrequency ablation 
Temporary measure only 
Radio Frequency Ablation 
Ethanol Injection 
HCC: Chemoembolization 
Inject chemotherapy selectively in hepatic 
artery 
Then inject an embolic agent 
Only in pt with early cirrhosis 
No role for systemic chemotherapy 
Chemoembolization 
Fibro-Lamellar Carcinoma 
Presents in young pt (5-35) 
Not related to cirrhosis 
AFP is normal 
CT shows typical stellate scar with radial 
septa showing persistant enhancement 
 
Secondary Liver 
Metastases 
The most common site for blood born 
metastases 
Common primaries : colon, breast, lung, 
stomach, pancreases, and melanoma 
Mild cholestatic picture (ALP, LDH) with 
preserved liver function 
Dx imaging or FNA 
Treatment depends on the primary cancer 
In some cases resection or chemoembolization 
is possible 
 
Summary 
Hemangioma 
Focal nodular 
hyperplasia 
Adenoma 
Liver cysts 
1. Primary liver 
cancers 
Hepatocellular 
carcinoma 
Fibrolamellar carcinoma 
Hepatoblastoma 
 
2.  Metastases 
Benign  Malignant